Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation?

Name: Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation?
Start: 2026-05-27T16:10
End: 2026-05-27T16:45
Location: Copthorne Tara Hotel London Kensington

Digi-Tech Pharma & AI 2026 · 27 May 2026 · 16:10–16:45

Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation? was a session at Digi-Tech Pharma & AI 2026 on 27 May 2026 in London, with 6 speakers on record.

Speakers

Olga Obrezanova — Panelist Principal Scientist, Augmented Biologics Design, AstraZeneca
Esben Jannik Bjerrum — Panelist Principal Research Scientist II, AI / ML Team Lead, AbbVie
Remco Loos — Panelist Senior Director, Bristol Myers Squibb
Mohammad Hassan Khalid — Panelist Head of AI/ML and Data Science, Portal Biotech
Konrad Dobschuetz — Panelist Chief Strategy Officer, McGinley Orthopedics
Frederik Buijs — Panelist Global Evidence Lead MS Franchise Integrated Evidence Planning, Roche